AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 201.36 |
Market Cap | 19.62B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 5.31 |
PE Ratio (ttm) | 44.17 |
Forward PE | n/a |
Analyst | Buy |
Ask | 370.15 |
Volume | 425,174 |
Avg. Volume (20D) | 603,249 |
Open | 233.15 |
Previous Close | 234.10 |
Day's Range | 229.16 - 234.72 |
52-Week Range | 191.97 - 247.99 |
Beta | undefined |
About LH
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin ...
Analyst Forecast
According to 18 analyst ratings, the average rating for LH stock is "Buy." The 12-month stock price forecast is $257.5, which is an increase of 9.78% from the latest price.
Next Earnings Release
Analysts project revenue of $3.30B, reflecting a 8.79% YoY growth and earnings per share of 3.45, making a 4.55% increase YoY.